Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
The FDA expands age range to younger population for use of bacterial meningitis vaccine. References and Resources FDA Expands Age Range for Use of Bacterial Meningitis Vaccine Click…
William Chey, MD, Professor, Department of Internal Medicine, University of Michigan Health System, discusses transmission of H. pylori. References and Resources Templeton R, Shared history of humans and…
William Chey, MD, Professor, Department of Internal Medicine, University of Michigan Health System, discusses the prevalence of H. pylori. References and Resources Konno M, Fujii N, Yokota S,…
The first inhaled insulin product, Exubera, has been discontinued due to dosing issues and pulmonary lung function test concerns. References and Resources Drug to be Discontinued; Exubera (insulin…
Philip Schoenfeld, MD, MSEd, MSc, Associate Professor, Department of Internal Medicine, University of Michigan Health System, discusses the risk of suicide in patients with chronic abdominal pain syndromes.…
The FDA advisory panel began two days of hearings to consider banning the sale of over-the-counter cough and cold medicines for young children. References and Resources Public Health…
Namrata Patel, MD, Assistant Professor in Medicine, Section of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses possible interventions for patients with IPF. References and…
Namrata Patel, MD, Assistant Professor in Medicine, Section of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses idiopathic pulmonary fibrosis. References and Resources Altube Urrengoetxea…
Curtis Miyamoto, MD, Chairperson/Professor, Department of Radiation Oncology, Temple University School of Medicine, discusses Intensity Modulated Radiation Therapy (IMRT). References and Resources A Message from Curtis Miyamoto, MD…
A meeting of the Circulatory System Devices Panel discussed the premarket approval for Endeavor, and voted unanimously in favor of “Approvable with Conditions.” References and Resources Circulatory System…
